Group One Trading, L.P. Caladrius Biosciences, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.41 - $0.74 $861 - $1,554	-2,100 Reduced 3.04%	67,014 $36,000
Q1 2022 May 12, 2022	BUY	$0.63 - $1.03 $17,757 - $29,032	28,187 Added 68.87%	69,114 $50,000
Q4 2021 Feb 11, 2022	BUY	$0.83 - $1.22 $21,698 - $31,894	26,143 Added 176.83%	40,927 $34,000
Q3 2021 Nov 12, 2021	BUY	$1.15 - $1.57 $17,001 - $23,210	14,784 New	14,784 $18,000
Q1 2021 May 12, 2021	SELL	$1.44 - $2.89 $3,444 - $6,912	-2,392 Closed	0 $0

Q3 2020 Nov 12, 2020	BUY	$1.6 - $3.0 $3,827 - $7,176	2,392 New	2,392 $4,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.